Navigation Links
ALS Therapy Development Institute and Anida Pharma Partner to Investigate Potential Treatments for ALS
Date:9/10/2013

e philanthropy investments in small biotechs like Anida Pharma. Previous venture philanthropy investments have been made with to-BBB, Neurotune, Regenesance, Glialogix, Aestus and others under confidential agreements.

"The possibility to partner with ALS TDI as a world-leading institute for ALS research is an extraordinary opportunity for Anida to accelerate its ALS drug development program towards the clinic. We believe that based on its unique property of multiple actions: regulating inflammation and cell death, but also exerting neurotrophic effects, NPD1 offers an exciting potential for the treatment of ALS," says Per Gjorstrup, M.D., Ph.D., President and CEO of Anida Pharma. 

About ALS
Amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) is a progressive neurodegenerative disease that leads to paralysis, due to the death of motor neurons in the spinal cord and brain. There is no known cure for the disease. About 5,000 people in the US are diagnosed with ALS each year; the incidence is similar to multiple sclerosis. However, with no effective treatment, the average patient survives only two to five years following diagnosis. There are about 30,000 people in the US diagnosed with ALS today. The worldwide population of ALS patients is estimated at 450,000.

About ALS Therapy Development Institute (ALS TDI)
The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) as soon as possible for patients today. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust target discovery program, while simultaneously operating the world's largest efforts to preclinically determine the efficacy of potential th
'/>"/>

SOURCE ALS Therapy Development Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
3. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
6. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
7. BHI Raises Awareness of Hearing Aids as Potential Therapy to Help Quiet "Ringing in the Ears" During National Tinnitus Awareness Week
8. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
9. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
10. Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy
11. The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: ... that specializes in developing safer, more effective cannabis-based ... C. Anderson , Ph.D., to its Scientific Advisory ... who brings significant drug discovery and development expertise ... synthetic organic chemist by training with more than ...
(Date:3/31/2015)... 31, 2015  CVS Health (NYSE: CVS ... clinical affiliations with Rush University Medical Center in ... Medical Center in Tucson, Arizona ... Care. These affiliations will help enhance access to ... these clinical affiliations, CVS Health will provide prescription ...
(Date:3/31/2015)... 31, 2015 Biorasi , a ... strategic partnership with Medidata , the leading ... in life sciences. Offering therapeutic expertise in a ... Medidata,s electronic data capture (EDC), management and reporting ... through IV global clinical trial business. ...
Breaking Medicine Technology:InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 2CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 4
... First Disease Database for the ... VentriPoint Diagnostic System, SEATTLE, ... (KBR) enables accurate three,dimensional reconstruction of right ventricular volume and ... time and for,a lower cost than currently applied methods., ...
... mid 2008 with Phase 2 development ... begin late in 2008 or in early 2009 -, SAN ... announced positive results from the Phase 1,proof-of-concept trial (n=30) of NU172, ... single bolus dose with a favorable safety profile., "There is ...
Cached Medicine Technology:Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients, According to VentriPoint Diagnostics 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 3Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 4
(Date:3/31/2015)... GA (PRWEB) March 31, 2015 When SIGVARIS ... the company’s most successful product launch to date. Women immediately ... SIGVARIS is giving women another reason to love EVERSHEER with ... time for spring. , Lavender mist pairs perfectly with ... and neutral outfits. For women looking to add a hint ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 India ... Insurance programs, issues a travel advisory to all USA ... costs in the United States are higher than many ... in developed countries. For example, a coronary artery ... same procedure costs about $34,358 . Visitors are ...
(Date:3/31/2015)... March 31, 2015 DentalXChange, ... specializes in providing online solutions to connect ... it has achieved full accreditation for the ... Accreditation Program (HNAP) from the Electronic Healthcare ... HNAP accreditation runs in two-year increments and ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 A' Design ... design project Bruker EVOQ by Daniel Dion has been ... Award in Scientific Instruments, Medical Devices and Research ... Daniel Dion, the creative mind behind the award winning ... MS - developed under the direction of Dr. Rohan ...
(Date:3/31/2015)... A team of Italian scientists is ... properties, into mesothelioma cancer cells. Surviving Mesothelioma has just ... website. Click here to read it now. ... to the spice turmeric, has limited value as a ... at Università di Napoli Federico II are getting around ...
Breaking Medicine News(10 mins):Health News:Put Spring in Your Step with SIGVARIS’ Top Selling Sheer Hosiery Compression Therapy Brand 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 3Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 2Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 3Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2
... today formally inducted 11 private healthcare providers into the public ... in the health sector. //Mr Blair and the health secretary, ... at Downing Street to mark the launch of NHS Partners ... work as partners towards 'future success' of the NHS. "Wherever ...
... are at a lesser risk of Parkinson’s, according to ... and Psychiatry. // ,The research team, as ... patients and 106 healthy people, belonging to the same ... sought to throw light on their personality traits and ...
... much as 140 million valuable lives, based on reports ... the report, internationally renowned economic modeller Warwick McKibbin and ... even a mild pandemic could kill 1.4 million people ... production. ,The report warned that developing effective ...
... millionaire currently living in Australia claims to have discovered ... worst form of attention deficit hyperactivity disorder (ADHD). //This ... astronauts returning from space. But it can also be ... rebalancing their brains. , ,Attention deficit hyperactivity disorder ...
... Electronics has said that it will start to roll out ... from using an enzyme contained in the "the pungent national ... dreaded bird flu virus. ,"We developed the filter ... spokeswoman Park Se-won said. The filter was fabricated after assessing ...
... against a Wall, to cough up more on Healthcare for its ... doing this for the cause of the workers, and improve their ... The scene is on the brink of a major tussle between ... scene at Washington is hotting up with the battle lines clearly ...
Cached Medicine News:
... KR-9000PW Wavefront Analyzer provides the practitioner ... visual analysis system on the market ... range auto refractometer, auto keratometer, and ... the benefits of wavefront measurement!, ,The ...
... The Worlds First Combination Unit, the ... Refractor, Keratometer, and Non-Contact Tonometer. By combining ... allows you to save time while providing ... trust from Marco. The M3 not only ...
... with a Lexan®inner calibrated flow tube has ... defects. A wide range of configurations are ... with all popular inlet connections, a 50 ... configurations. Our extra large knob coupled with ...
... with a Lexan®inner calibrated flow tube has ... defects. A wide range of configurations are ... with all popular inlet connections, a 50 ... configurations. Our extra large knob coupled with ...
Medicine Products: